Immunopathologia Persa
Published by Nickan Research Institute
eISSN : 2423-8015
Abbreviation : Immunopathol. Persa
Aims & Scope
Immunopathologia Persa is an international peer-reviewed journal which includes the study of the pathology often organ system, an organism or a disease with respect to the immune system, immunity, and immune responses.
This journal also contains immunologic mechanisms of injury, and major autoimmune diseases.
Immunopathologia Persa helps clinicians and pathologists to better know the immune responses associated with disease and aimed to grow up the developments in the field of immunopathology.
The subject of immunopathology is a dynamic, and rapidly growing, subspecialty of both immunology and pathology.
Journal of Immunopathologia Persa includes some of the most important features of immnulogic basis of the disease.
The scientific research international Journal of Immunopathologia Persa (Immunopathol Persa) is a peer-reviewed journal devoted to the promotion of treatment of immunopathologic aspects of the diseases.
It publishes every six months in March and September of each year.
It has pursued this aim through publishing editorials, original research articles, reviews, mini-reviews, commentaries, letters to the editor, hypothesis, case reports, epidemiology and prevention, news and views, brief communications and photo-clinics.
View Aims & ScopeMetrics & Ranking
Journal Rank
| Year | Value |
|---|---|
| 2024 | 22028 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 75 |
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 0.187 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q4 |
h-index
| Year | Value |
|---|---|
| 2024 | 9 |
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.